客服公告:反詐騙!提醒您「不碰ATM、網銀,不說信用卡資料」詳情

  • 防疫專區
  • 電子票券
  • 每日簽到
  • 今日66折
  • 天天BUY
The $800 Million Pill: The Truth Behind the Cost of New Drugs

The $800 Million Pill: The Truth Behind the Cost of New Drugs

  • 作者: Goozner, Merrill
  • 原文出版社:University of California Press
  • 出版日期:2005/10/10
  • 語言:英文
  • 定價:1348
  • 運送方式:
  • 臺灣與離島
  • 海外
  • 可配送點:台灣、蘭嶼、綠島、澎湖、金門、馬祖
  • 可取貨點:台灣、蘭嶼、綠島、澎湖、金門、馬祖
載入中...
  • 分享
 

內容簡介

Why do life-saving prescription drugs cost so much? Drug companies insist that prices reflect the millions they invest in research and development. In this gripping expos , Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying astronomically high prices for prescription drugs. Goozner demonstrates that almost all the important new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and at the National Institutes of Health. He reports that once the innovative work is over, the pharmaceutical industry often steps in to reap the profit.

Goozner shows how drug innovation is driven by dedicated scientists intent on finding cures for diseases, not by pharmaceutical firms whose bottom line often takes precedence over the advance of medicine. A university biochemist who spent twenty years searching for a single blood protein that later became the best-selling biotech drug in the world, a government employee who discovered the causes for dozens of crippling genetic disorders, and the Department of Energy-funded research that made the Human Genome Project possible--these engrossing accounts illustrate how medical breakthroughs actually take place.

The $800 Million Pill suggests ways that the government's role in testing new medicines could be expanded to eliminate the private sector waste driving up the cost of existing drugs. Pharmaceutical firms should be compelled to refocus their human and financial resources on true medical innovation, Goozner insists. This book is essential reading for everyone concerned about the politically charged topics of drug pricing, Medicare coverage, national health care, and the role of pharmaceutical companies in developing countries.

 

作者簡介

Merrill Goozner is former Chief Economics Correspondent at the Chicago Tribune. Winner of six Peter Lisagor Awards, Goozner is a contributing editor for The American Prospect. His work has also appeared in the New York Times, Washington Post, Boston Magazine, Columbia Journalism Review, Washington Monthly, Fortune Small Business, Slate.com, and Salon.com, among other publications.

 

詳細資料

  • ISBN:9780520246706
  • 規格:平裝 / 297頁 / 22.4 x 15.2 x 2.3 cm / 普通級
  • 出版地:美國

最近瀏覽商品

 

相關活動

  • 識別潛在危機,探索全球競爭與裂變。新知領航,與中信出版同行,參展書5折起,精選3本73折。
 

購物說明

外文館商品版本:商品之書封,為出版社提供之樣本。實際出貨商品,以出版社所提供之現有版本為主。關於外文書裝訂、版本上的差異,請參考【外文書的小知識】。定價匯率為:美金乘以35,英磅乘以55。部份書籍,因出版社供應狀況特殊,匯率依實際狀況做調整。

調貨時間:無庫存之商品,在您完成訂單程序之後,將以空運的方式為您下單調貨。原則上約10~14個工作天可以取書(若有將延遲另行告知)。為了縮短等待的時間,建議您將外文書與其它商品分開下單,以獲得最快的取貨速度,但若是海外專案進口的外文商品,調貨時間約1~2個月。 

若您具有法人身份為常態性且大量購書者,或有特殊作業需求,建議您可洽詢「企業採購」。 

退換貨說明 

會員所購買的商品均享有到貨十天的猶豫期(含例假日)。退回之商品必須於猶豫期內寄回。 

辦理退換貨時,商品必須是全新狀態與完整包裝(請注意保持商品本體、配件、贈品、保證書、原廠包裝及所有附隨文件或資料的完整性,切勿缺漏任何配件或損毀原廠外盒)。退回商品無法回復原狀者,恐將影響退貨權益或需負擔部分費用。 

訂購本商品前請務必詳閱商品退換貨原則 

  • 文學季
  • puzzle
  • 繪本

訂閱電子報

想獲得最新商品資訊,請訂閱免費電子報